跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
SFDA
/
MYOZYME 50mg Powder For Concentrate For Solution For Infusion
Authorized
BIOLOGICAL
MYOZYME 50mg Powder For Concentrate For Solution For Infusion
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
b0afd03623cc2e4d
Company
Unknown
Type
Biological
Approval Details
Approval Id
b0afd03623cc2e4d
Drug Approval Sfda Name
MYOZYME 50mg Powder For Concentrate For Solution For Infusion
Trade Name
MYOZYME 50mg Powder For Concentrate For Solution For Infusion
Generic Name
ALGLUCOSIDASE ALFA
Register Number
1402244920
Register Year
2017
Drug Type
Biological
Route Of Administration
Intravenous use
Package Type
Vial
Package Size
1
Size
10
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store in a refrigerator (2°c – 8°c)
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000000042-5-100000074029
Price
2606
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
b0afd03623cc2e4d
Type
Biological
Back to SFDA Approvals
MYOZYME 50mg Powder For Concentrate For Solution For Infusion - SFDA Drug Approval Details
